Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
AIMS: The antidiabetic drug metformin is currently used prior and during pregnancy for polycystic ovary syndrome, as well as during gestational diabetes mellitus. We investigated the effects of prenatal metformin exposure on the metabolic phenotype of the offspring during adulthood in mice. METHODS: Metformin (300 mg/kg) or vehicle was administered orally to dams on regular diet from the embryonic day E0.5 to E17.5. Gene expression profiles in liver and brain were analysed from 4-day old offspring by microarray. Body weight development and several metabolic parameters of offspring were monitored both during regular diet (RD-phase) and high fat diet (HFD-phase). At the end of the study, two doses of metformin or vehicle were given acutely to mice at the age of 20 weeks, and Insig-1 and GLUT4 mRNA expressions in liver and fat tissue were analysed using qRT-PCR. RESULTS: Metformin exposed fetuses were lighter at E18.5. There was no effect of metformin on the maternal body weight development or food intake. Metformin exposed offspring gained more body weight and mesenteric fat during the HFD-phase. The male offspring also had impaired glucose tolerance and elevated fasting glucose during the HFD-phase. Moreover, the expression of GLUT4 mRNA was down-regulated in epididymal fat in male offspring prenatally exposed to metformin. Based on the microarray and subsequent qRT-PCR analyses, the expression of Insig-1 was changed in the liver of neonatal mice exposed to metformin prenatally. Furthermore, metformin up-regulated the expression of Insig-1 later in development. Gene set enrichment analysis based on preliminary microarray data identified several differentially enriched pathways both in control and metformin exposed mice. CONCLUSIONS: The present study shows that prenatal metformin exposure causes long-term programming effects on the metabolic phenotype during high fat diet in mice. This should be taken into consideration when using metformin as a therapeutic agent during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metformin-exposed mice gained more weight postnatally, and the male offspring, when they were fed a HFD, became more adipose and more of them developed glucose intolerance than placebo-exposed offspring.17”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [17]
In the citing paper
“In a mouse model, in which pregnant dams were lean and fed with their usual chow, metformin treatment was associated with the offspring being lighter at birth, with a similar phenotype to offspring exposed to undernutrition in utero.17”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524 · cited 1×
“In order to calculate the human dose, an allometric body surface area method (BSA) [35] was used.”
MethodRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 6×
“AMPK is a cellular energy regulator that activates ATP-producing metabolic pathways [5,6] and autophagy [7,8] to normalise the energy balance of the cells.”
BackgroundInfluentialKEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
The fetal and infant origins of adult disease.
Barker, D. J. (1990) · BMJ · doi:10.1136/bmj.301.6761.1111 · Cited by 2,768
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Cited by
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Hanem, L. G. E., Salvesen, Ø., Juliusson, P. B., Carlsen, S. M., Nossum, M. C. F., Vaage, M. Ø., Ødegård, R., & Vanky, E. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30385-7 · Cited by 134
Ijäs, H., Vääräsmäki, M., Saarela, T., Keravuo, R., & Raudaskoski, T. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12964 · Cited by 139
Izzo, A., Nitti, M. P., Mollo, N., Paladino, S., Procaccini, C., Faicchia, D., Calì, G., Genesio, R., Bonfiglio, F., Cicatiello, R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx016 · Cited by 112
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
Metformin in Reproductive Biology
Faure, M., Bertoldo, M. J., Khoueiry, R., Bongrani, A., Brion, F., Giulivi, C., Dupont, J., & Froment, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00675 · Cited by 109
Metformin induces PGC‐1α expression and selectively affects hepatic PGC‐1α functions
Aatsinki, S., Buler, M., Salomäki, H., Koulu, M., Pavek, P., & Hakkola, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12585 · Cited by 85
Self-citationOwen, M. D., Baker, B., SCOTT, E. M., & Forbes, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115759 · Cited by 98
Metformin in the management of diabetes during pregnancy and lactation
Priya, G., & Kalra, S. (2018) · Drugs in Context · doi:10.7573/dic.212523 · Cited by 99
Nutrition and its role in epigenetic inheritance of obesity and diabetes across generations
Kaspar, D., Hastreiter, S., Irmler, M., de Angelis, M. H., & Beckers, J. (2020) · Mammalian Genome · doi:10.1007/s00335-020-09839-z · Cited by 89
Metformin from mother to unborn child-are there unwarranted effects?
Nguyen, L., Chan, S.-Y., & Teo, A. K. K. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.047 · Cited by 67
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options
Mirabelli, M., CHIEFARI, E. D., Tocci, V., Greco, E. A., FOTI, D. P., & Brunetti, A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.06.003 · Cited by 75
Environmental monitoring and the developmental origins of health and disease
Almeida, D. L., Pavanello, A., Saavedra, L. P. J., Pereira, T. S., de Castro‐Prado, M. A. A., & Mathias, P. C. D. F. (2019) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174419000151 · Cited by 74
Salomäki, H., Heinäniemi, M., Vähätalo, L. H., Ailanen, L., Eerola, K., Ruohonen, S. T., Pesonen, U., & Koulu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115778 · Cited by 63
Self-citationDevelopmental programming by maternal obesity: Lessons from animal models
Schoonejans, J. M., & Ozanne, S. E. (2021) · Diabetic Medicine · doi:10.1111/dme.14694 · Cited by 70
Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation.
Bertoldo, M. J., Faure, M., Dupont, J., & Froment, P. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.04 · Cited by 67
Anisimov, V. N., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Yurova, M. N., Semenchenko, A. V., Tyndyk, M. L., Panchenko, A. V., Trashkov, A. P., Vasiliev, A. G., et al. (2015) · Cell Cycle · doi:10.4161/15384101.2014.973308 · Cited by 55
van Weelden, W., Wekker, V., de Wit, L., Limpens, J., Nikkinen, H., Leemhuis, A. G., Roseboom, T. J., van Rijn, B. B., DeVries, J. H., & Painter, R. C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0479-0 · Cited by 57
Efficacy and safety of metformin during pregnancy: an update
Paschou, S. Α., Shalit, A., Gerontiti, E., Athanasiadou, K. I., Kalampokas, T., Ψαλτοπούλου, Θ., Lambrinoudaki, I. V., Anastasiou, E., Wolffenbuttel, B. H. R., & Goulis, D. G. (2023) · Endocrine · doi:10.1007/s12020-023-03550-0 · Cited by 60
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth-Hansen, A., Salvesen, Ø., Engen Hanem, L. G., Eggebø, T., Salvesen, K. Å., Vanky, E., & Ødegård, R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01191 · Cited by 47
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 49
Hufnagel, A., Fernandez‐Twinn, D. S., Blackmore, H. L., Ashmore, T. J., Heaton, R. A., Jenkins, B., Koulman, A., Hargreaves, I. P., Aiken, C., & Ozanne, S. E. (2021) · The Journal of Physiology · doi:10.1113/jp281902 · Cited by 69
Tertti, K., Toppari, J., Virtanen, H. E., Sadov, S., & Rönnemaa, T. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.59 · Cited by 40
H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses
Deng, J., Mueller, M., Geng, T., Shen, Y., Liu, Y., Hou, P., Ramillapalli, R., Taylor, H. S., Paidas, M. J., & Huang, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.392 · Cited by 37
Maternal obesity and offspring health: Adapting metabolic changes through autophagy and mitophagy
Wang, L., O’Kane, A., Zhang, Y., & Ren, J. T. (2023) · Obesity Reviews · doi:10.1111/obr.13567 · Cited by 42
Salomäki-Myftari, H., Vähätalo, L. H., Ailanen, L., Pietilä, S., Laiho, A., Hänninen, A., Pursiheimo, J.-P., Munukka, E., Rintala, A., Savontaus, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163805 · Cited by 33
Self-citationXie, X., Liu, J., Pujol, I., López, A., Martínez, M. J., García-Patterson, A., Adelantado, J. M., Ginovart, G., & Corcoy, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103343 · Cited by 32
Schoonejans, J. M., Blackmore, H. L., Ashmore, T. J., Aiken, C., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158104 · Cited by 39
Hill, D. J., & Hill, T. G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1456629 · Cited by 47
Schoonejans, J. M., Blackmore, H. L., Ashmore, T. J., Pantaleão, L. C., Pisani, L. P., Dearden, L., Tadross, J. A., Aiken, C., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2022) · Diabetologia · doi:10.1007/s00125-022-05789-0 · Cited by 33
Gregg, B. E., Botezatu, N., Brill, J. D., Hafner, H., Vadrevu, S., Satin, L. S., Alejandro, E. U., & Bernal‐Mizrachi, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-23965-4 · Cited by 25
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
Tocci, V., Mirabelli, M., Salatino, A., Sicilia, L., Giuliano, S., Brunetti, F. S., CHIEFARI, E. D., Sarro, G. D., FOTI, D. P., & Brunetti, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091318 · Cited by 39
Brawerman, G. M., & Dolinsky, V. W. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.002 · Cited by 32
Placental dysfunction in obese women and antenatal surveillance strategies
Jeve, Y. B., Konje, J. C., & Doshani, A. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.09.007 · Cited by 30
Singh, P., Garg, R., Goand, U. K., Riyazuddin, M., Reza, M. I., Ahmed, S. A., Gupta, A. P., Husain, A., & Gayen, J. R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05133 · Cited by 22
Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
Raperport, C., Chronopoulou, E., & Homburg, R. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1889366 · Cited by 26
Metformin Disrupts Signaling and Metabolism in Fetal Hepatocytes
Swenson, K. S., Wang, D., Jones, A. K., Nash, M. J., O’Rourke, R., Takahashi, D. L., Kievit, P., Hennebold, J. D., Aagaard, K. M., Friedman, J. E., et al. (2023) · Diabetes · doi:10.2337/db23-0089 · Cited by 23
Zhang, Y., Liu, X., Yang, L., & Zou, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.596145 · Cited by 16
Anthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero
Nilsen, G. Ø., Simpson, M. R., Hanem, L. G. E., Løvvik, T. S., Ødegård, R. A., Stokkeland, L. M. T., Andersen, M., Júlíusson, P. B., & Vanky, E. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14637 · Cited by 18
Zheng, Z., Li, Y., Fan, S., An, J., Luo, X., Liang, M., Zhu, F., & Huang, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03536-8 · Cited by 16
In Utero Exposure to Metformin Reduces the Fertility of Male Offspring in Adulthood
Faure, M., Khoueiry, R., Quanico, J. P., Acloque, H., Guerquin, M.-J., Bertoldo, M. J., Chevaleyre, C., Ramé, C., Fournier, I., Salzet, M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.750145 · Cited by 18
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth‐Hansen, A. K., Salvesen, Ø. O., Hanem, E., Eggebø, T. M., Salvesen, K., Vanky, E., & Ødegård, R. A. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.2.21 · Cited by 15
Metformin Decreases Hyaluronan Synthesis by Vascular Smooth Muscle Cells
Sainio, A., Takabe, P., Oikari, S., Salomäki, H., Koulu, M., Söderström, M., Pasonen‐Seppänen, S., & Järveläinen, H. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001156 · Cited by 15
Self-citationHarris, K., Desai, N., Gupta, M., Xue, X., Chatterjee, P. K., Rochelson, B. L., & Metz, C. N. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0115-9 · Cited by 16
Song, L., Cui, J., Hu, S., Wang, R., Li, H., & Sun, B. (2022) · Nutrients · doi:10.3390/nu14173612 · Cited by 15
Metformin Perturbs Pancreatic Differentiation From Human Embryonic Stem Cells
Nguyen, L. T. V., Lim, L. Y., Ding, S. S. L., Amirruddin, N. S., Hoon, S. S., Chan, S., & Teo, A. K. K. (2021) · Diabetes · doi:10.2337/db20-0722 · Cited by 17
Zhang, F.-F., Zhang, Q., Wang, Y.-L., Wang, F., Hardiman, P., & Qu, F. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.01.018 · Cited by 14
Should metformin be included in fertility treatment of PCOS patients?
Haas, J., & Bentov, Y. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.012 · Cited by 14
Pharmacotherapy for hyperglycemia in pregnancy – Do oral agents have a place?
Corcoy, R., Balsells, M., García‐Patterson, A., Shmueli, A., & Hadar, E. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.015 · Cited by 13
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond
Newman, C., Rabbitt, L., Ero, A., & Dunne, F. (2023) · Drugs · doi:10.1007/s40265-023-01899-0 · Cited by 14
Hebert, J. F., & Myatt, L. (2023) · Antioxidants · doi:10.3390/antiox12030719 · Cited by 12
Perinatal Outcomes in Type 2 Diabetes
Hewapathirana, N. M., & Murphy, H. R. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0461-1 · Cited by 12
Vidigal, C. B., Novi, D. R. B. S., Moura, K. F., Picinin, R., Montagnini, B. G., da Silva, R. D. N. O., da Silva, M. D. V., de Andrade, F. G., Akamine, E. H., Gerardin, D. C. C., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.050 · Cited by 9
Novi, D. R. B. S., Vidigal, C. B., Marques, B. V. D., Forcato, S., Raquel, H. D. A., Zaia, D. A. M., Zaia, C. T. B. V., Martins‐Pinge, M. C., Gerardin, D. C. C., & Ceravolo, G. S. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1517804 · Cited by 11
Developmental effects of in utero metformin exposure.
Carroll, D. T., Sassin, A. M., Aagaard, K. M., & GANNON, M. A. (2021) · PubMed · Cited by 13
Paavilainen, E., Nyman, A. H., Niinikoski, H., Nikkinen, H., Veijola, R., Vääräsmäki, M., Tossavainen, P. H., Rönnemaa, T., & Tertti, K. (2023) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001233 · Cited by 30
Forcato, S., Montagnini, B. G., de Góes, M. L. M., Novi, D. R. B. S., Kiss, A. C. I., Ceravolo, G. S., & Gerardin, D. C. C. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.04.009 · Cited by 11
Prenatal metformin treatment improves ovarian function in offspring of obese rats
Álvarez, D., Ceballo, K., Olguín, S., Martínez-Pinto, J., Maliqueo, M. A., Fernandois, D., Sotomayor‐Zárate, R., & Cruz, G. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0352 · Cited by 9
Novi, D. R. B. S., Forcato, S., Vidigal, C. B., Loiola, G. H., Gerardin, D. C. C., & Ceravolo, G. S. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000520 · Cited by 10
Is metformin safe in pregnancy: a focus on offspring outcomes
Malek, R., & Davis, S. N. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2424410 · Cited by 11
Hafner, H., Mulcahy, M. C., Carlson, Z., Hartley, P., Sun, H., Westerhoff, M. A., Qi, N., Bridges, D., & Gregg, B. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.759690 · Cited by 8
Advances in Research on Down Syndrome
Dey, S. (2018) · InTech eBooks · doi:10.5772/intechopen.68260 · Cited by 7
Rowan, J., Rush, E. C., & Plank, L. D. (2023) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13739 · Cited by 7
Cantacorps, L., Zhu, J., Yagoub, S., Coull, B. M., Falck, J. E., Chesters, R., Ritter, K., Serrano-Lope, M. A., Tscherepentschuk, K., Kasch, L.-S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101860 · Cited by 6
The diversity of gestational diabetes: a therapeutic challenge
Qvigstad, E. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0012 · Cited by 7
van Hoorn, E. G. M., Rademaker, D., van der Wel, A. W. T., DeVries, J. H., Franx, A., van Rijn, B. B., Kooy, A., Siegelaar, S. E., Roseboom, T. J., Ozanne, S. E., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.15243 · Cited by 6
Long-term effects of metformin use in gestational diabetes mellitus on offspring health
Roy, A., & Sahoo, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1812 · Cited by 5
Vora, N. L., Grace, M. R., Smeester, L., Dotters-Katz, S. K., Fry, R. C., Bae-Jump, V. L., & Boggess, K. (2018) · Reproductive Sciences · doi:10.1177/1933719118786453 · Cited by 5
Cardiovascular outcome in 12‐month‐old male and female offspring of metformin‐treated obese mice
Schoonejans, J. M., Wilsmore, P., Mennitti, L. V., Wong, K. K., Ashmore, T. J., Garrud, T. A. C., Blackmore, H. L., Patey, O. V., Fernandez‐Twinn, D. S., Giussani, D. A., et al. (2025) · The Journal of Physiology · doi:10.1113/jp288696 · Cited by 3
Wang, L., Hu, R., Yao, Z., Zhang, L., Li, Q., Li, R., Sun, Q., & Liu, C. (2025) · Environment & Health · doi:10.1021/envhealth.5c00262 · Cited by 3
Mitochondrial Abnormalities in Down Syndrome: Pathogenesis, Effects and Therapeutic Approaches
Izzo, A., Mollo, N., Cicatiello, R., Genesio, R., Paladino, S., Conti, A. M. F., & Nitsch, L. (2018) · InTech eBooks · doi:10.5772/intechopen.71059 · Cited by 4
Song, K.-H., Lee, M., Yoo, C., Lim, S., & Choe, B. (2018) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2018.01.004 · Cited by 3
Vieira, H. R., Gonçalves, G. D., Alves, V. S., Melo, M. A. B., Borges, S. C., Klagenberg, J., Neves, C. Q., Previate, C., Saavedra, L. P. J., Siervo, G. E. M. D. L., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115712 · Cited by 3
Jiang, X.-Y., Chen, D.-W., Duan, T., Zhang, J.-D., Ren, Y., & Tan, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1744305 · Cited by 4
Newman, C., Alvarez‐Iglesias, A., Eyers, K., McEvoy, R. P., O’Shea, P. M., Gillespie, P., Devane, D., Egan, A. M., Simpkin, A. J., Zhu, Y., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04778-z · Cited by 3
Kanat, M., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70987 · Cited by 1
Abdillah, R., Rachmaini, F., Fadhilah, D., & Almahdy, A. (2024) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2023-0352 · Cited by 1
Dennison, C. A. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25816 · Cited by 1
Exposition fœtale à la metformine : un atout pour la descendance ?
Dubois‐Laforgue, D. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30179-6
Maternal Metabolic State and Cancer Risk: An Evolving Manifestation of Generational Impact
Simmen, F. A., Heard, M. E., Pabona, J. M. P., Fernandes, L. M., Mercado, C. P., & Simmen, R. C. M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6386-7_13
Screening and treatment of diabetes in obese pregnant women
Visser, G. H. A., & de Valk, H. W. (2013) · doi:10.2217/ebo.13.537
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci19-0025
Perinatal nutrition and metabolic disease
Cruz, G., Fernandois, D., Jorquera, G., Llanos, P., Maliqueo, M. A., & Molina, X. E. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813862-5.00009-8
Metformin in pregnancy: a re‐examination of its safety
Simmons, R. (2021) · The Journal of Physiology · doi:10.1113/jp282324
Dorra, T., Chamiah, S., Mansour, A., & Atwa, A. (2021) · Journal of Animal and Poultry Production · doi:10.21608/jappmu.2021.219985
Fung, S. S.-P. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-024-01047-y
Kou, H., & Guo, Y. (2024) · Springer eBooks · doi:10.1007/978-981-97-5730-5_12
Amica-Carpenter, A., Cox, D. R., Sylvestre, Y., Roberts, S. A., Perchard, R., Calloway, E., Richardson, K., & Myers, J. (2025) · Trials · doi:10.1186/s13063-025-09154-5
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
Scairati, R., Newman, C., Alvarez‐Iglesias, A., Smyth, A., O’Shea, P. M., Devane, D., Gillespie, P., Egan, A. M., O'Donnell, M. J., & Dunne, F. (2026) · Trials · doi:10.1186/s13063-026-09703-6 · Cited by 1
Metadata
- Authors
- Salomäki, H., Vähätalo, L. H., Laurila, K., Jäppinen, N. T., Penttinen, A.-M., Ailanen, L., Ilyasizadeh, J., Pesonen, U., & Koulu, M.
- Affiliations
- University of Turku (FI)
- Aalto University (FI)
- Corresponding author
- Koulu, Markku
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-15
- Volume
- 8
- Issue
- 2
- Pages
- e56594
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3574083
- OpenAlex
- W2063226778
- Cited by
- 92
- References
- 64
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 11 · 2022: 3 · 2021: 16 · 2020: 6 · 2019: 6 · 2018: 19 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 7 · 2013: 2
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-10-16)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Aaltodoc (Aalto University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Kela
- Academy of Finland (134131)
- Turun Yliopisto
- Turun Yliopistollinen Keskussairaala
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, prenatal drug exposure, developmental programming, high-fat diet, glucose tolerance, GLUT4, INSIG1, hepatic gene expression, adipose tissue, weight gain, polycystic ovary syndrome, gestational diabetes mellitus
- MeSH terms
- Animals, Body Weight, Eating, Female, Fetus, Gene Expression Regulation, Glucose Tolerance Test, Hypoglycemic Agents, Liver, Male, Membrane Proteins, Metformin, Mice, Inbred C57BL, Organ Size, Phenotype, Pregnancy, Prenatal Exposure Delayed Effects, Maternal Exposure, Glucose Transporter Type 4, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.